A complete mutation screen of the ADPKD genes by DHPLC

Kidney International

Volumn 61, Issue 5, 2002, Pages 1588-1599

  Rossetti, Sandro ^a,b,c,d   Chauveau, Dominique ^a,b,c,d   Walker, Denise ^a,b,c,d   Saggar Malik, Anand ^a,b,c,d   Winearls, Christopher G ^a,b,c,d   Torres, Vicente E ^a,b,c,d   Harris, Peter C ^a,b,c,d  

^a MAYO CLINIC   (United States)

^b INSERM   (France)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autosomal dominant polycystic kidney disease; Denaturing high performance liquid chromatography; Mutations; PKD1; PKD2

Indexed keywords

DNA FRAGMENT;

AMPLICON; ARTICLE; BASE PAIRING; CHROMOSOME 16P; CHROMOSOME 4Q; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVICE; DIAGNOSTIC PROCEDURE; EXON; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY POLYCYSTIC DISEASE; MISSENSE MUTATION; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0036239770     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00326.x     Document Type: Article

References (42)

1. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
2. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains
3. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein
4. PKD 2, a gene for polycystic kidney disease that encodes an integral membrane protein
5. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease
6. Comparison of phenotypes of polycystic kidney disease types 1 and 2
7. Human disease: Calcium signaling in polycystic kidney disease
8. Genome duplications and other features in 12 Mbp of DNA sequence from human chromosome 16p and 16q
9. Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications
10. A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)
11. A spectrum of mutations in the polycystic kidney disease 2 (PKD2) gene from eight Canadian kindreds
12. Seven novel mutations of the PKD 2 gene in families with autosomal dominant polycystic kidney disease
13. Identification of mutations in the duplicated region of the polycystic kidney disease 1 (PKD1) gene by a novel approach
14. Gene conversion is a likely cause of mutation in PKD1
15. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease
16. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR
17. Thirteen novel mutations of the replicated region of PKD 1 in an Asian population
18. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples
19. Novel mutations in the duplicated region of PKD1 gene
20. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)
21. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis
22. Denaturing high-performance liquid chromatography: A review
23. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1
24. Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2)
25. Theory of DNA melting curves
26. Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: Expression of mutated genes
27. The structure of a PKD domain from polycystin-1: Implication for polycystic kidney disease
28. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains
29. The PLAT domain: A new piece in the PKD 1 puzzle
30. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): Major implications for genetic counselling
31. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2
32. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis
33. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: Usefulness and limitations
34. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions
35. DGGE screening of PKD1 gene reveals novel mutations in a large cohort of 146 unrelated patients
36. Screening the 3′ region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations
37. A 2.5 kb polypyrimidine tract in PKD1 gene contains at least 23 H-DNA-forming sequences
38. The nature and mechanisms of human gene mutation
39. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing
40. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1
41. Autosomal dominant polycystic kidney disease (ADPKD) in an Italian family carrying a novel nonsense mutation and two missense changes in exon 44 and 45 of the PKD1 gene
42. Mutational analysis within the 33 region of the PKD1 gene